Cadila Healthcare informs about press release

13 Sep 2018 Evaluate

Cadila Healthcare has informed about press release titled, 'Zydus receives final approval from the USFDA for Risedronate Sodium Delayed-Release Tablets'.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1008.15 10.70 (1.07%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.20
Dr. Reddys Lab 5820.00
Cipla 1423.85
Zydus Lifesciences 1008.15
Lupin 1659.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.